Free Trial

Rep. Lisa C. McClain Purchases Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background

Key Points

  • Rep. Lisa C. McClain purchased shares of Option Care Health, Inc. (NASDAQ:OPCH) worth between $1,001 and $15,000 on September 25th, as disclosed in a filing on October 22nd.
  • The current stock price of Option Care Health is $28.04, with a market capitalization of $4.55 billion and a twelve-month price range between $21.39 and $35.53.
  • Research analysts have given a consensus rating of "Moderate Buy" for Option Care Health, with nine analysts recommending a Buy and an average price target of $35.10.
  • Interested in Option Care Health? Here are five stocks we like better.

Representative Lisa C. McClain (R-Michigan) recently bought shares of Option Care Health, Inc. NASDAQ: OPCH. In a filing disclosed on October 22nd, the Representative disclosed that they had bought between $1,001 and $15,000 in Option Care Health stock on September 25th. The trade occurred in the Representative's "CHARLES SCHWAB BROKERAGE ACCOUNT 924" account.

Representative Lisa C. McClain also recently made the following trade(s):

  • Purchased $1,001 - $15,000 in shares of FMC NYSE: FMC on 9/25/2025.
  • Sold $1,001 - $15,000 in shares of Merit Medical Systems NASDAQ: MMSI on 9/25/2025.
  • Purchased $1,001 - $15,000 in shares of Darden Restaurants NYSE: DRI on 9/25/2025.
  • Purchased $1,001 - $15,000 in shares of ASML NASDAQ: ASML on 9/25/2025.
  • Purchased $1,001 - $15,000 in shares of Kenvue NYSE: KVUE on 9/25/2025.
  • Sold $1,001 - $15,000 in shares of Beacon Financial NYSE: BBT on 9/25/2025.
  • Sold $1,001 - $15,000 in shares of British American Tobacco NYSE: BTI on 9/25/2025.
  • Purchased $1,001 - $15,000 in shares of Rollins NYSE: ROL on 9/25/2025.
  • Purchased $1,001 - $15,000 in shares of SAP NYSE: SAP on 9/25/2025.
  • Purchased $1,001 - $15,000 in shares of MGP Ingredients NASDAQ: MGPI on 9/25/2025.

Option Care Health Price Performance

Shares of Option Care Health stock opened at $28.04 on Friday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a market capitalization of $4.55 billion, a P/E ratio of 22.43, a PEG ratio of 1.72 and a beta of 0.88. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The business's fifty day moving average price is $28.00 and its 200 day moving average price is $30.15.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The firm had revenue of $1.42 billion for the quarter, compared to analysts' expectations of $1.35 billion. During the same quarter last year, the firm earned $0.30 earnings per share. The firm's revenue for the quarter was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, research analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have commented on the company. JMP Securities raised their price objective on Option Care Health from $36.00 to $38.00 and gave the company a "market outperform" rating in a research report on Thursday, July 31st. Weiss Ratings reaffirmed a "hold (c)" rating on shares of Option Care Health in a research report on Wednesday, October 8th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a research report on Tuesday, September 23rd. Cowen began coverage on Option Care Health in a research report on Thursday, October 2nd. They set a "hold" rating on the stock. Finally, Morgan Stanley began coverage on Option Care Health in a research report on Friday, October 17th. They set an "overweight" rating and a $35.00 target price on the stock. Nine equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $35.10.

Check Out Our Latest Stock Analysis on Option Care Health

Hedge Funds Weigh In On Option Care Health

A number of hedge funds have recently bought and sold shares of OPCH. Durable Capital Partners LP grew its stake in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company's stock worth $267,557,000 after purchasing an additional 4,720,988 shares in the last quarter. Norges Bank acquired a new position in Option Care Health in the second quarter worth about $69,932,000. Nuveen LLC acquired a new position in Option Care Health in the first quarter worth about $70,965,000. Swedbank AB acquired a new position in Option Care Health in the third quarter worth about $49,455,000. Finally, Arrowstreet Capital Limited Partnership grew its stake in Option Care Health by 109.0% in the second quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company's stock worth $110,770,000 after purchasing an additional 1,778,279 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The stock was acquired at an average cost of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the purchase, the director owned 375,390 shares of the company's stock, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Norman L. Wright purchased 3,411 shares of the firm's stock in a transaction that occurred on Tuesday, September 9th. The stock was purchased at an average price of $29.31 per share, with a total value of $99,976.41. Following the completion of the purchase, the director directly owned 15,501 shares of the company's stock, valued at approximately $454,334.31. This represents a 28.21% increase in their position. The disclosure for this purchase can be found here. Over the last three months, insiders bought 59,411 shares of company stock worth $1,627,576. Corporate insiders own 0.64% of the company's stock.

About Representative McClain

Lisa McClain (Republican Party) is a member of the U.S. House, representing Michigan's 9th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027. McClain (Republican Party) is running for re-election to the U.S. House to represent Michigan's 9th Congressional District. She declared candidacy for the 2026 election. Lisa McClain lives in Romeo, Michigan. McClain earned a bachelor's degree in business administration from Northwood University. Her career experience includes founding and working as the president of North End Support Team.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Option Care Health Right Now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.